ATKR vs NBIX · rev $2.85B vs P/E 45, rev $1.77B
Atkore International Group Inc (ATKR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Atkore International Group Inc (ATKR) is a electrical equipment & parts company listed on NYSE.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ATKR revenue for 2025-09-30 was $2.85B. Net income was -$15.2M. ATKR currently screens at market cap $2.69B.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ATKR currently screens at market cap $2.69B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ATKR and NBIX stock pages for the full models.
Not investment advice.